AstraZeneca is Hiring Diagnostic Strategy Senior Director
Ashley Easter, Head of Strategy and Partnerships, Global Oncology Diagnostics at AstraZeneca, shared a post on LinkedIn:
“I’m hiring! We are looking for a dynamic, experienced, and well-connected leader to develop our commercial AI and multimodal diagnostic strategy. Come and join our AstraZeneca Global Oncology Diagnostics Strategy team!
We anticipate rapid advancements in and utility for AI and multimodal diagnostic tools in oncology, so we are thinking ahead to how these will be implemented in oncology clinical practice. This person will be responsible for developing our commercial AI and multimodal biomarker/diagnostic platform strategy – including elements such as deployment of CDx/SaMD, integration of multiple modes of data, and understanding fragmented hospital ecosystems.
The role will be based in either of our main hubs in Gaithersburg, MD or Cambridge, UK.”
More posts featuring AstraZeneca on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023